Analyzing a Genome per Day

Technology company Knome unveils a machine it says will "break the bottleneck" in the interpretation of human genome data.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers will now be able to interpret one human genome for less than $400, according to toolmaker Knome. The washing machine-sized knoSYS 100, which Knome unveiled last week (September 27), costs $125,000 and weighs in at 600 pounds. Knome, which was cofounded in 2007 by pioneering synthetic biologist George Church of Harvard University, has been generating vanity genomes for high-profile clients such as Ozzy Osbourne and analyzing human genome data sent in by researchers. Now, the knoSYS100 essentially puts Knome's analysis services in a box that genomic researchers can keep in their labs. "People need accurate interpretations that they have control over," Church told Forbes. "They don’t want to be forced to send stuff out. That’s an awful lot of data that’s quite sensitive."

The knoSYS 100 is also designed to help whittle down the mountains of genomic data researchers are generating as the cost and speed of sequencing plummets ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development